Skip to content
Bomb Report – Lifestyle
Author:
20/20 Biolabs Inc.
20/20 BioLabs to Participate in the Maxim Growth Summit 2026 in New York on October 14, 2026
October 2, 2026
20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise Model
September 29, 2026
10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
August 28, 2026
20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level
August 17, 2026
20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour
July 30, 2026
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy
July 27, 2026
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock
July 23, 2026
20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth
July 9, 2026
20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month
June 22, 2026
20/20 Biolabs’ Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters
May 27, 2026
1
2
Next Page
→